MedElevator
Войти в исследования Sante publique (Vandoeuvre-les-Nancy, France) · 2025
[Not Available].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Layba Camara Mariame, Kagbadouno Moïse, Kourouma Ansoumane, Diallo Mamadou Baîlo, Soumah Alseny M'Mah, Camara Oumou, Mutumbo Wilfried, Ngolo Digas, Lubukulu Génèse, Musawu Yannick, Ilboudo Hamidou, Bart Jean Mathieu, Camara Mamadou, Kokolomami Jack
Аннотация
OBJECTIVE: To evaluate the feasibility of launching the new human African trypanosomiasis (HAT) drug and its use in the three endemic foci in Guinea.
METHODOLOGY: An analytical cross-sectional study was conducted to assess the feasibility of this implementation in the foci of Boffa, Dubréka, and Forécariah located on the Guinean coast.
RESULTS: The results of this study showed that (i) nearly one in three respondents (27.5%) had good knowledge of how HAT is transmitted, and (ii) half of the respondents (49.6%) had heard of a new treatment for HAT. Most of the respondents recognized that it has the advantages of not requiring a lumbar puncture (61.4%) and of being free of charge (38.6%). Almost all respondents would readily accept oral HAT treatment (99.3%) and would even be willing to take it at home (98.3%). Many of them would feel less stigmatized by following this treatment.
CONCLUSION: Although the knowledge required, favorable attitude, and practices amenable to adopting this new treatment varied, depending on the study site and level of education, the respondents largely indicated that they would be confident in adopting this new treatment.
METHODOLOGY: An analytical cross-sectional study was conducted to assess the feasibility of this implementation in the foci of Boffa, Dubréka, and Forécariah located on the Guinean coast.
RESULTS: The results of this study showed that (i) nearly one in three respondents (27.5%) had good knowledge of how HAT is transmitted, and (ii) half of the respondents (49.6%) had heard of a new treatment for HAT. Most of the respondents recognized that it has the advantages of not requiring a lumbar puncture (61.4%) and of being free of charge (38.6%). Almost all respondents would readily accept oral HAT treatment (99.3%) and would even be willing to take it at home (98.3%). Many of them would feel less stigmatized by following this treatment.
CONCLUSION: Although the knowledge required, favorable attitude, and practices amenable to adopting this new treatment varied, depending on the study site and level of education, the respondents largely indicated that they would be confident in adopting this new treatment.